Magali Taiel

Company: GenSight Biologics

Job title: Chief Medical Officer

Seminars:

Designing & Delivering Early Access for Gene Therapies: Lessons from Lenadogene Nolparvovec in Leber Hereditary Optic Neuropathy 10:30 am

• Meeting urgent unmet need in Leber Hereditary Optic Neuropathy through early access • Exploring unique considerations for gene therapy in rare disease populations • Overcoming operational, regulatory, and logistical hurdles throughout the EAP journey • Actionable insights and takeaways for future gene therapy early access programmesRead more

day: Day 2